Yijin Chen
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesis.
Journal: Journal of hematology & oncology
Published: March 04, 2025
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies.
Journal: Experimental hematology & oncology
Published: August 29, 2024
Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective study.
Journal: Bone marrow transplantation
Published: August 28, 2024
ELTD1 inhibits differentiation of hemogenic endothelium progenitors from human embryonic stem cells through the HPIP-Wnt pathway.
Journal: Experimental & molecular medicine
Published: July 25, 2024
Establishment of a humanized mouse model using steady-state peripheral blood-derived hematopoietic stem and progenitor cells facilitates screening of cancer-targeted T-cell repertoires.
Journal: Cancer innovation
Published: October 17, 2023
Correction: Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges.
Journal: Cell regeneration (London, England)
Published: October 08, 2023
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges.
Journal: Cell regeneration (London, England)
Published: May 26, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026